Bio-Path Holdings, Inc. (BPTH) financial statements (2021 and earlier)

Company profile

Business Address 4710 BELLAIRE BOULEVARD
BELLAIRE, TX 77401
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1420169914
Cash and cash equivalents1420169914
Prepaid expense11010  
Other current assets1110100
Other undisclosed current assets     10
Total current assets:162227111014
Noncurrent Assets
Operating lease, right-of-use asset00
Property, plant and equipment0001100
Intangible assets, net (including goodwill)   1111
Intangible assets, net (excluding goodwill)   1111
Total noncurrent assets:1101211
TOTAL ASSETS:162329121115
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1111110
Accounts payable0010000
Accrued liabilities1101110
Debt 0     
Due to related parties      0
Deferred revenue and credits 0  
Other undisclosed current liabilities0     0
Total current liabilities:1111111
Noncurrent Liabilities
Long-term debt and lease obligation00     
Operating lease, liability00
Liabilities, other than long-term debt    3  
Derivative instruments and hedges, liabilities    3  
Other undisclosed noncurrent liabilities(0)      
Total noncurrent liabilities:00  3  
Total liabilities:1211411
Stockholders' equity
Stockholders' equity attributable to parent, including:15211881015
Common stock0000000
Additional paid in capital82774947403535
Accumulated deficit(67)(56)(48)(39)(32)(25) 
Other undisclosed stockholders' equity attributable to parent      (20)
Total stockholders' equity:15211881015
TOTAL LIABILITIES AND EQUITY:162329121115

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues   00  
Cost of revenue
(Cost of Goods and Services Sold)
      (0)
Gross profit:   00 (0)
Operating expenses(11)(9)(9)(9)(8)(5)(5)
Other undisclosed operating income      0
Operating loss:(11)(9)(9)(9)(8)(5)(5)
Nonoperating income0002200
Investment income, nonoperating0000000
Interest and debt expense   (0)   
Loss from continuing operations before equity method investments, income taxes:(11)(9)(9)(7)(7)(5)(5)
Other undisclosed income from continuing operations before income taxes   0   
Loss from continuing operations before income taxes:(11)(9)(9)(7)(7)(5)(5)
Income tax expense (benefit)(0)(0)(0)0  (0)
Net loss:(11)(9)(9)(7)(7)(5)(5)
Other undisclosed net income (loss) attributable to parent000(0)  0
Net loss attributable to parent:(11)(9)(9)(7)(7)(5)(5)
Preferred stock dividends and other adjustments   (1)   
Net loss available to common stockholders, diluted:(11)(9)(9)(8)(7)(5)(5)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(11)(9)(9)(7)(7)(5)(5)
Comprehensive loss, net of tax, attributable to parent:(11)(9)(9)(7)(7)(5)(5)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: